163 related articles for article (PubMed ID: 37205848)
1. Repression of TRIM13 by chromatin assembly factor CHAF1B is critical for AML development.
Dean ST; Ishikawa C; Zhu X; Walulik S; Nixon T; Jordan JK; Henderson S; Wyder M; Salomonis N; Wunderlich M; Greis KD; Starczynowski DT; Volk AG
Blood Adv; 2023 Sep; 7(17):4822-4837. PubMed ID: 37205848
[TBL] [Abstract][Full Text] [Related]
2. Altered DNA methylation of TRIM13 in diabetic nephropathy suppresses mesangial collagen synthesis by promoting ubiquitination of CHOP.
Li Y; Ren D; Shen Y; Zheng X; Xu G
EBioMedicine; 2020 Jan; 51():102582. PubMed ID: 31901873
[TBL] [Abstract][Full Text] [Related]
3. A CHAF1B-Dependent Molecular Switch in Hematopoiesis and Leukemia Pathogenesis.
Volk A; Liang K; Suraneni P; Li X; Zhao J; Bulic M; Marshall S; Pulakanti K; Malinge S; Taub J; Ge Y; Rao S; Bartom E; Shilatifard A; Crispino JD
Cancer Cell; 2018 Nov; 34(5):707-723.e7. PubMed ID: 30423293
[TBL] [Abstract][Full Text] [Related]
4. Trim13 Potentiates Toll-Like Receptor 2-Mediated Nuclear Factor
Huang B; Baek SH
Mol Pharmacol; 2017 Apr; 91(4):307-316. PubMed ID: 28087809
[TBL] [Abstract][Full Text] [Related]
5. TRIM13 regulates ubiquitination and turnover of NEMO to suppress TNF induced NF-κB activation.
Tomar D; Singh R
Cell Signal; 2014 Dec; 26(12):2606-13. PubMed ID: 25152375
[TBL] [Abstract][Full Text] [Related]
6. The transmembrane endoplasmic reticulum-associated E3 ubiquitin ligase TRIM13 restrains the pathogenic-DNA-triggered inflammatory response.
Li X; Yu Z; Fang Q; Yang M; Huang J; Li Z; Wang J; Chen T
Sci Adv; 2022 Jan; 8(4):eabh0496. PubMed ID: 35080984
[TBL] [Abstract][Full Text] [Related]
7. The E3 ubiquitin ligase Trim13 regulates Nur77 stability via casein kinase 2α.
Huang B; Pei HZ; Chang HW; Baek SH
Sci Rep; 2018 Sep; 8(1):13895. PubMed ID: 30224829
[TBL] [Abstract][Full Text] [Related]
8. TRIM13 is a negative regulator of MDA5-mediated type I interferon production.
Narayan K; Waggoner L; Pham ST; Hendricks GL; Waggoner SN; Conlon J; Wang JP; Fitzgerald KA; Kang J
J Virol; 2014 Sep; 88(18):10748-57. PubMed ID: 25008915
[TBL] [Abstract][Full Text] [Related]
9. CHAF1b, chromatin assembly factor-1 subunit b, is essential for mouse preimplantation embryos.
Zhang Y; Yang Y; Qiao P; Wang X; Yu R; Sun H; Xing X; Zhang Y; Su J
Int J Biol Macromol; 2022 Jan; 195():547-557. PubMed ID: 34906611
[TBL] [Abstract][Full Text] [Related]
10. ZNF521 Enhances MLL-AF9-Dependent Hematopoietic Stem Cell Transformation in Acute Myeloid Leukemias by Altering the Gene Expression Landscape.
Chiarella E; Aloisio A; Scicchitano S; Todoerti K; Cosentino EG; Lico D; Neri A; Amodio N; Bond HM; Mesuraca M
Int J Mol Sci; 2021 Oct; 22(19):. PubMed ID: 34639154
[TBL] [Abstract][Full Text] [Related]
11. Hypomethylation and expression of BEX2, IGSF4 and TIMP3 indicative of MLL translocations in acute myeloid leukemia.
Röhrs S; Dirks WG; Meyer C; Marschalek R; Scherr M; Slany R; Wallace A; Drexler HG; Quentmeier H
Mol Cancer; 2009 Oct; 8():86. PubMed ID: 19835597
[TBL] [Abstract][Full Text] [Related]
12. Loss of MBD2 attenuates MLL-AF9-driven leukemogenesis by suppressing the leukemic cell cycle via CDKN1C.
Zhou K; Zhou M; Cheng L; Chen X; Wang X; Chu Y; Yu Q; Zhang S; Wang N; Zhao L; Wang D; Huang L; Wang C; Yuan W; Zhou J
Oncogenesis; 2021 Nov; 10(11):79. PubMed ID: 34789717
[TBL] [Abstract][Full Text] [Related]
13. The E3 ubiquitin ligase Triad1 influences development of Mll-Ell-induced acute myeloid leukemia.
Wang H; Bei L; Shah CA; Huang W; Platanias LC; Eklund EA
Oncogene; 2018 May; 37(19):2532-2544. PubMed ID: 29459712
[TBL] [Abstract][Full Text] [Related]
14. SUV39H1 regulates the progression of MLL-AF9-induced acute myeloid leukemia.
Chu Y; Chen Y; Guo H; Li M; Wang B; Shi D; Cheng X; Guan J; Wang X; Xue C; Cheng T; Shi J; Yuan W
Oncogene; 2020 Dec; 39(50):7239-7252. PubMed ID: 33037410
[TBL] [Abstract][Full Text] [Related]
15. WT1 facilitates the self-renewal of leukemia-initiating cells through the upregulation of BCL2L2: WT1-BCL2L2 axis as a new acute myeloid leukemia therapy target.
Zhou B; Jin X; Jin W; Huang X; Wu Y; Li H; Zhu W; Qin X; Ye H; Gao S
J Transl Med; 2020 Jun; 18(1):254. PubMed ID: 32580769
[TBL] [Abstract][Full Text] [Related]
16. Brain-specific deletion of TRIM13 promotes metabolic stress-triggered insulin resistance, glucose intolerance, and neuroinflammation.
Qian Y; Lei G; Wen L
Biochem Biophys Res Commun; 2020 Jun; 527(1):138-145. PubMed ID: 32446357
[TBL] [Abstract][Full Text] [Related]
17. Hes1 suppresses acute myeloid leukemia development through FLT3 repression.
Kato T; Sakata-Yanagimoto M; Nishikii H; Ueno M; Miyake Y; Yokoyama Y; Asabe Y; Kamada Y; Muto H; Obara N; Suzukawa K; Hasegawa Y; Kitabayashi I; Uchida K; Hirao A; Yagita H; Kageyama R; Chiba S
Leukemia; 2015 Mar; 29(3):576-85. PubMed ID: 25234168
[TBL] [Abstract][Full Text] [Related]
18. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
[TBL] [Abstract][Full Text] [Related]
19. Identification of MLL-fusion/MYC⊣miR-26⊣TET1 signaling circuit in MLL-rearranged leukemia.
Huang H; Jiang X; Wang J; Li Y; Song CX; Chen P; Li S; Gurbuxani S; Arnovitz S; Wang Y; Weng H; Neilly MB; He C; Li Z; Chen J
Cancer Lett; 2016 Mar; 372(2):157-65. PubMed ID: 26791235
[TBL] [Abstract][Full Text] [Related]
20. An aberrantly sustained emergency granulopoiesis response accelerates postchemotherapy relapse in
Wang H; Shah CA; Hu L; Huang W; Platanias LC; Eklund EA
J Biol Chem; 2020 Jul; 295(28):9663-9675. PubMed ID: 32467231
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
